BridgeMD
Compares treatment options for Dietary Monitoring
Official title Assessing User Satisfaction and Adherence to an Abbreviated Dietary Tracking App (MySnackTracker) Versus Full-intake Dietary Monitoring
ClinicalTrials.gov ID: NCT06919471
What this study is testing
- What it's testing
- To learn if a method of abbreviated food tracking (called MySnackTracker) is a reasonable alternative to traditional full-intake food tracking and to compare the adherence to and acceptability of each method.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Eligibility Criteria In order to be eligible to participate in this study, an participants must meet all of the following criteria:
- Provision of signed and dated informed consent form
- Access to internet connection, email address, and smartphone able to download the intervention app
- Current or previous participation in one of the following DFI cohorts: PA17-0584 (MERIT Study), Project CHURCH, High Risk Breast Cohort...
- Demonstrated ability to read and understand English. The study app is currently only available in English.
You likely can't join if
- An participant who meets any of the following criteria will be excluded from participation in this study:
- Prisoners
- Anyone currently under 18 years of age
- Cognitively impaired participants
- Pregnant women (assessed by self-report)
- BMI less than 28 or greater than 40
See the full eligibility criteria
- Eligibility Criteria In order to be eligible to participate in this study, an participants must meet all of the following criteria:
- Provision of signed and dated informed consent form
- Access to internet connection, email address, and smartphone able to download the intervention app
- Current or previous participation in one of the following DFI cohorts: PA17-0584 (MERIT Study), Project CHURCH, High Risk Breast Cohort, Mexican-American Cohort, and rural cancer survivors from the Mind Your BEAT study
- Demonstrated ability to read and understand English. The study app is currently only available in English.
- An participant who meets any of the following criteria will be excluded from participation in this study:
- Prisoners
- Anyone currently under 18 years of age
- Cognitively impaired participants
- Pregnant women (assessed by self-report)
- BMI less than 28 or greater than 40
- Self-reported previous or planned bariatric surgery
- Self-reported current or planned use of a GLP-1 agonist medication
- Self-reported current or planned participation in another weight loss intervention
- Cancer participants receiving active treatment
- Anyone currently unable to participate in the research for the duration of the study
- No current motivation to lose weight
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.